Outcome of Infected Cardiac Device Re-implantation in Erbil Cardiac Center-Iraq

Mohammed Hasan  Alwan

doi:10.56056/amj.2024.298

Authors

Mohammed Hasan Alwan M.B.Ch.B_F.I.C.M.S(Med)_F.I.C.M.S(Cardiol). Asst.Prof. Consultant. Interventional Cardiologist. Medicine department College of medicine, Hawler Medical University

DOI:

https://doi.org/10.56056/amj.2024.298

Keywords:

Infected box, Permanent pacemaker, Re-implantation

Abstract

Background & Objectives: Cardiac electronic devices have been in clinical practice for more than 6 decades. Infection is not uncommon with these devices due to their scarcity and exorbitant cost which makes them inaccessible to a significant number of patients. Therefore, the only method to source them is to reimplant used devices. The problem of possible infection as result of reusing these devices has not been previously investigated in Iraq. The objective of the current study was to find the outcomes of the re-implanted infected device.

Methods: Ten patients with infected boxes (complete or partial dehiscence with or without pus discharge) were included in this case-series study, from January 2016 to January 2023 in Erbil cardiac center, All the patients were well informed that their re-sterilized devices will be re-implanted, and verbal informed consents were obtained from all patients.

Results: Ten procedures for ten patients with permanent pacemaker infected boxes had been done. The patients’ age ranged from 1.5 to 77 years, and all of them were males. Nine infections had been cured and followed for six months to 7 years. One patient died after 12 months (1.5 years old child with severe heart failure).

Conclusion: Re-implantation of infected box after sterilization had high success rate.

Downloads

Download data is not yet available.

References

Senning A. Cardiac pacing in retrospect. Am J Surg. 1983;145(6):733-9.

Sandoe JA, Barlow G, Chambers JB, Gammage M, Guleri A, Howard P, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 2015;70(2):325-59.

Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22(4):515-49.

Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011;171(20):1821-8.

Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001-6.

Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33(4):414-9.

Palmisano P, Accogli M, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, et al. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy. Europace. 2013;15(4):531-40.

Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol. 2010;33(6):705-11.

Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol. 2012;60(16):1540-5.

Kennergren C. Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients. Arrhythm Electrophysiol Rev. 2015;4(1):53-7.

Borleffs CJ, Thijssen J, de Bie MK, van Rees JB, van Welsenes GH, van Erven L, et al. Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol. 2010;33(8):1013-9.

Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116(12):1349-55.

Dai M, Cai C, Vaibhav V, Sohail MR, Hayes DL, Hodge DO, et al. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study. JACC Clin Electrophysiol. 2019;5(9):1071-80.

Olsen T, Jørgensen OD, Nielsen JC, Thøgersen AM, Philbert BT, Johansen JB. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018). Eur Heart J. 2019;40(23):1862-9.

Diemberger I, Biffi M, Lorenzetti S, Martignani C, Raffaelli E, Ziacchi M, et al. Predictors of long-term survival free from relapses after extraction of infected CIED. EP Europace. 2017;20(6):1018-27.

Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006;48(3):590-1.

de Bie MK, van Rees JB, Thijssen J, Borleffs CJ, Trines SA, Cannegieter SC, et al. Cardiac device infections are associated with a significant mortality risk. Heart Rhythm. 2012;9(4):494-8.

Uslan DZ, Gleva MJ, Warren DK, Mela T, Chung MK, Gottipaty V, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing Clin Electrophysiol. 2012;35(1):81-7.

Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH, 3rd, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6(7):1085-104.

Toriello F, Saviano M, Faggiano A, Gentile D, Provenzale G, Pollina AV, et al. Cardiac Implantable Electronic Devices Infection Assessment, Diagnosis and Management: A Review of the Literature. J Clin Med. 2022;11(19).

Modi Atig A, Alhamad YI, Alanizi FS, Ardah HI, Alanazi H. Retrospective study of post-operative infections in implantable cardiac devices in a cardiac tertiary care center. Ann Saudi Med. 2022;42(1):58-63.

Ngiam JN, Liong TS, Sim MY, Chew NWS, Sia CH, Chan SP, et al. Risk Factors for Mortality in Cardiac Implantable Electronic Device (CIED) Infections: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11(11).

Baman TS, Meier P, Romero J, Gakenheimer L, Kirkpatrick JN, Sovitch P, et al. Safety of pacemaker reuse: a meta-analysis with implications for underserved nations. Circ Arrhythm Electrophysiol. 2011;4(3):318-23.

Sinha SK, Sivasambu B, Yenokyan G, Crawford TC, Chrispin J, Eagle KA, et al. Worldwide pacemaker and defibrillator reuse: Systematic review and meta-analysis of contemporary trials. Pacing Clin Electrophysiol. 2018;41(11):1500-7.

Boyle TA, Uslan DZ, Prutkin JM, Greenspon AJ, Baddour LM, Danik SB, et al. Reimplantation and Repeat Infection After Cardiac-Implantable Electronic Device Infections: Experience from the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) Database. Circ Arrhythm Electrophysiol. 2017;10(3).

Yu CM, Yu CM, Yao WT, Lee YH, Liao FC, Chien CY, et al. Safety and Efficacy of Submuscular Implantation with Resterilized Cardiac Implantable Electronic Device in Patients with Device Infection: A Retrospective Observational Study in Taiwan. Open Forum Infect Dis. 2022;9(5): ofac100.